69452-254-22 : NDC 2026 Code

69452-254-22 : Etravirine ( Etravirine )

Additionally :

You can get information about “69452-254-22” NDC code in 69452-254-22 in HTML format

HTML | 69452-254-22 in TXT (Plain Text) format

TXT | 69452-254-22 in PDF (Portable Document Format)

PDF | 69452-254-22 in XML format

XML formats.

NDC Code : 69452-254-22 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69452-254-22",
    "PackageDescription": "120 TABLET in 1 BOTTLE, PLASTIC (69452-254-22) ",
    "NDC11Code": "69452-0254-22",
    "ProductNDC": "69452-254",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Etravirine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Etravirine",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260101",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA219152",
    "LabelerName": "Bionpharma Inc.",
    "SubstanceName": "ETRAVIRINE",
    "StrengthNumber": "100",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20260101",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}